MEMORANDUM OPINION
Plaintiff brought this Freedom of Information Act (“FOIA”) suit to compel the U.S. Department of Health and Human Services (“HHS”) to release thirty documents relating to the competitive grant application process of the National Institutes of Health (“NIH”). Defendant moved for summary judgment on the grounds that the documents are protected from disclosure under FOIA Exemptions 5 and 6. 5 U.S.C. §§ 552(b)(5) & (6). On July 1,1997, at the conclusion of oral argument on defendant’s motion, I directed the government to present two documents (# 1 and # 24) for in camera review. Plaintiff subsequently narrowed his FOIA demand to a single document, # 24, and to information in the other requested documents relating to the reliability of a specific technology used to measure lead in bone.
Background
The documents sought in this case were created as part of the peer review process NIH uses to determine which research grants it will fund. NIH enlists groups of expert scientists — Scientific Review Groups (“SRGs”) — to evaluate the scientific merits and significance of applications and make recommendations as to whether they should be funded. The SRGs consider factors such as the importance of the proposed research problem; the originality of the approach; the training, experience, and research competence of the investigators; the adequacy of the experimental design; the suitability of facilities; and the appropriateness of the requested budget relative to the proposed work. The SRGs create a “summary statement” for each application, setting forth a summary of the factors considered by the group and a recommendation for or against funding. The summary statement is presented to an advisory council that reviews all the applications in a particular scientific area.
Plaintiffs narrowed demand now seeks release of Document #24, which is a letter written by a grant applicant to an official at NIH in response to comments about his application made in an SRG report, as well as any comments found in the originally requested summary statements that deal with the reliability of LXRF technology as a method of measuring lead in bone. I have concluded, for the reasons set forth below, that FOIA Exemption 5 protects all the requested information from disclosure.
Analysis
Exemption 5 protects “inter-agency or intra-agency memorandums or letters which would not be available by law to a party ... in litigation with the agency.” 5 U.S.C. § 552(b)(5). This exemption has been interpreted to encompass all documents normally privileged in the civil discovery context, including documents that fall within the “deliberative process” privilege. NLRB v. Sears, Roebuck & Co.,
To qualify for Exemption 5, information must be “predecisional” and “deliberative.” See Access Reports v. Dep’t of Justice,
The summary statements reflect the collective views of SRGs on a wide variety of issues relevant to the feasibility and value of research proposals submitted to NIH. The Deputy Director for Extramural Research at NIH declares that public disclosure of reviewer comments would discourage candid and honest evaluations of applications because the reviewers would be reluctant to inflict harm on the professional reputation of applicants. Baldwin Decl. at 10-11. According to NIH, eliminating the confidentiality of the peer review process would render the process “dysfunctional” and would result in funding decisions that are “less informed, less fair, and less likely to achieve the best results for NIH and for the public good.” Baldwin Deck at 11. HHS asserts on the basis of that declaration that disclosure of the summary statements would undermine the deliberative process that characterizes NIH’s competitive grant application process.
I find — and plaintiff has all but conceded — that the opinions expressed in SRG reports are “deliberative” in nature and that their disclosure would adversely affect the decision-making process at NIH. See Formaldehyde Institute,
It is not necessary to undertake a fact-intensive analysis of whether release of specific statements relating to LXRF technology would undermine the NIH’s deliberative process. Release of deliberative statements that bear directly on the exercise of the agency’s policy judgment — including those that refer to LXRF technology — is not required by FOIA. There is no need to dissect and analyze each withheld portion of the documents. Examining whether disclosure of each specific statement contained in a deliberative document undermines the deliberative process would be needlessly complicated and would encourage the submission of self-serving, boilerplate affidavits from agencies that mimic the operative standards of law.
Document 24 is a letter written in 1992 by Dr. John P. Rosen, an applicant for funding, to Dr. Annette G. Kirshner, an official at NIH. Dr. Rosen’s letter responds to statements about his application made in an SRG report. After inspection of the SRG report and Dr. Rosen’s letter in camera, I
The parties have not cited and the Court has not found a case that squarely answers the question, but FBI v. Abramson,
An appropriate order accompanies this memorandum.
ORDER
For the reasons explained in the accompanying memorandum, it is this 8th day of September, 1997,
ORDERED that defendant’s motion for summary judgment [# 9] is granted. It is
FURTHER ORDERED that this case is dismissed.
Notes
. At some point in the review process, the SRG’s report is also provided to the applicant.
. This conclusion makes it unnecessary to decide whether Exemption 6 might apply.
. If individualized analysis of the harm to agency deliberations caused by release of specific state-merits about LXRF technology were required, the present record would need more development.
